Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 19, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 19, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 20, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 19, 2020 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Mar 19, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 11, 2020 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Mar 11, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 6, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 4, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Sep 4, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 4, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 14, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 12, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 12, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 12, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 15, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 13, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 13, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 13, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 13, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 14, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 12, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 12, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 12, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 12, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 26, 2017 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
| Sep 25, 2017 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Sep 12, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 1, 2017 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Aug 2, 2017 | TMBN | T | TTAB RELEASE CASE TO TRADEMARKS | Loading... |
| Aug 2, 2017 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| Aug 2, 2017 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Aug 18, 2016 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Aug 2, 2016 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
| Aug 1, 2016 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Jul 20, 2016 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| May 18, 2016 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Mar 22, 2016 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Mar 22, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 22, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 2, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 17, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 10, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 9, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 9, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 9, 2016 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 3, 2016 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Feb 3, 2016 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Jan 23, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 23, 2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment and prophylaxis of infectious diseases, immune system diseases and disorders, auto immune system diseases, and blood disorders, none of the foregoing related to oncology
Class 042
Research and development in the pharmaceutical and biotechnology fields, none of the foregoing related to oncology
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RESEARCH AND DEVELOPMENT"